COMMUNIQUÉS West-GlobeNewswire

Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV
14/02/2019
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries "), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products, has [...]
Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
14/02/2019
LEXINGTON, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Drinkworks™ Doubles Down on Recycling Solutions with Loop Industries, Inc.
14/02/2019
Partnership with Loop Industries will Provide a Free Mail-back Program for Cocktail, Cider and Beer Enthusiasts Seeking to Ensure Drinkworks Products are Upcycled BEDFORD, Mass. and MONTREAL, Feb. 14, 2019 (GLOBE [...]
RTI Surgical® Schedules Fourth Quarter and Full Year 2018 Earnings Call for February 28, 2019
14/02/2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) -- RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to release financial results from the fourth quarter and full year 2018 on [...]
Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019
14/02/2019
BUFFALO, N.Y., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call and Webcast on February 19, 2019
14/02/2019
Conference Call and Webcast Scheduled for Tuesday, February 19, 2019 at 8:00 a.m. ET MALVERN, Pa., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical [...]
EyePoint Pharmaceuticals Announces Fiscal Period Ended December 31, 2018 Financial Results Release Date and Conference Call Information
14/02/2019
WATERTOWN, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will [...]
Evelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
14/02/2019
-- First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in Metastatic Melanoma -- -- Preclinical Studies Have Shown Non-replicating Monoclonal Microbials Maintain Activity: EDP1867 in Development [...]
Axogen, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26, 2019
14/02/2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced [...]
Agios Reports Fourth Quarter and Full Year 2018 Financial Results
14/02/2019
– Strong Launch of TIBSOVO ® Continues with Net Revenue of $9.4M for the Fourth Quarter and $13.8M for Full Year 2018 – – Phase 3 ClarIDHy Trial of TIBSOVO ® in Second Line or Later Cholangiocarcinoma Fully Enrolled [...]
Aravive Expands Executive Team with Promotion of Gail McIntyre, PhD, DABT to Chief Scientific Officer
14/02/2019
HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that the company has promoted Gail McIntyre, PhD, DABT to chief scientific officer. “Aravive [...]
Breathtec Announces Name Change to Algernon Pharmaceuticals
14/02/2019
New corporate identity aligned with the Company's main strategy to be a global leader in the treatment of liver disease (NASH), chronic kidney disease and inflammatory bowel disease. The company's ticker symbol will [...]
Canada House Wellness Group Inc. Accelerates Phenotyping of 62 In-House Genetics
14/02/2019
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) and Abba Medix Corp. (“Abba”), CHV’s wholly owned Licensed Producer has accelerated their [...]
Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company
14/02/2019
Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapies Axovant will receive a preferred equity stake in Arvelle, which has received [...]
Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria
14/02/2019
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that Nestlé Health Science has exercised its option to obtain an exclusive license [...]
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
14/02/2019
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Terveystalo Plc: Notice of the Annual General Meeting
14/02/2019
Terveystalo Plc Stock Exchange Release 14 February 2019 at 9:05 EET Notice is given to the shareholders of Terveystalo Plc of the Annual General Meeting to be held on Thursday, 4 April 2019 at 3:00 p.m. at Marina [...]
Terveystalo Plc: Terveystalo Group Financial Statements Bulletin 2018
14/02/2019
Terveystalo Plc Stock Exchange Release 14 February 2019 at 9:00 EET Record year, strong platform for growth October-December 2018 in brief Revenue increased by 4.2 percent year-on-year to EUR 197.9 million (189.9) [...]
Ossur Hf : Annual General Meeting 7 March 2019
14/02/2019
Announcement no. 10/2019 14 February 2019 Össur hf. - Annual General Meeting 7 March 2019 Össur hf.'s Annual General Meeting will be held on Thursday 7 March 2019 at 9:00 am (GMT) at the Company's offices at Grjótháls 5 [...]

Pages